Woodford Investment Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Woodford Investment Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-833,081	Closed	-$63M	–	3
2019 Q3	$63M	Sell	833,081 -82,508	-9%	-$6.34M	20.31%	2
2019 Q2	$91.2M	Buy	915,589 +146,007	+19%	+$11.3M	15.43%	4
2019 Q1	$40.4M	Buy	769,582 +130,036	+20%	+$7.04M	3.26%	8
2018 Q4	$40.2M	Hold	639,546	–	–	3.48%	7
2018 Q3	$38.9M	Hold	639,546	–	–	3.09%	7
2018 Q2	$26M	Buy	639,546 +141,843	+28%	+$11.2M	3.15%	7
2018 Q1	$47.4M	Buy	+497,703	New	+$63.9M	4.22%	5

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LFS

Link Fund Solutions London, United Kingdom $157M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Woodford Investment Management's EVFM Position: Q4 2019 in Review

Woodford Investment Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2019, closing a stake of 833,081 shares — an estimated $63M sold.

Woodford Investment Management first reported a position in EVFM in Q1 2018 and held it in 7 quarters. The position peaked at $91.2M in Q2 2019. 42 funds tracked by Wall St. Rank hold EVFM as of Q4 2019.

Woodford Investment Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Woodford Investment Management sold 833,081 Evofem Biosciences, Inc. Common Stock shares in Q4 2019, an estimated $63M.
Woodford Investment Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Woodford Investment Management's Evofem Biosciences, Inc. Common Stock position peaked at $91.2M in Q2 2019.
42 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2019.

Based on Woodford Investment Management's 13F filing for Q4 2019.